7 results found.
... Non-Hodgkins Lymphoma News- Return to News Menu MabThera: Primary endpoints of phase III trial met two years early due to superior efficacy benefits in relapsed indolent non-Hodgkin's lymphoma Roche has been informed that a phase III study1 ...
Score: 102 - 15 Oct 2006 - URL: http://www.non-hodgkins-lymphoma-cancer.org/news/non-hodgkins-news0021.htm
... rituximab compared to CVP as first-line treatment for advanced follicular lymphoma. Blood. 2005;105:1417-1423. MabThera: Primary endpoints of phase III trial met two years early due to superior efficacy benefits in relapsed indolent ...
Score: 81 - 15 Oct 2006 - URL: http://www.non-hodgkins-lymphoma-cancer.org/news/nhl-news0010.htm
... Non-Hodgkins Lymphoma News- Return to News Menu Breakthrough MabThera data now shows patients with indolent Non-Hodgkin ’ s Lymphoma can live longer 7 December 2004- For the first time, clear data shows that treating Indolent Non-Hodgkin ...
Score: 69 - 15 Oct 2006 - URL: http://www.non-hodgkins-lymphoma-cancer.org/news/non-hodgkins-news0022.htm
... Non-Hodgkins Lymphoma News- Return to News Menu MabThera maintenance therapy dramatically improves survival for patients with lymphoma Risk of death halved- Roche files label extension in Europe for maintenance therapy 12 December 2005- Two years of ...
Score: 61 - 31 Aug 2007 - URL: http://www.non-hodgkins-lymphoma-cancer.org/news/non-hodgkins-news0023.htm
... Schneiderman wants to bring public attention to the issue again on a larger stage. Roche gets European approval for MabThera in first line treatment of indolent non-Hodgkin ’ s lymphoma Vital treatment option brings benefit to patients across Europe ...
Score: 57 - 15 Oct 2006 - URL: http://www.non-hodgkins-lymphoma-cancer.org/news/nhl-news0005.htm
... recurrence of non-Hodgkins lymphoma, is one of the first patients to receive acupuncture treatments at the cancer center. MabThera maintenance therapy dramatically improves survival for patients with lymphoma Two years of maintenance therapy with MabThera (rituximab) ...
Score: 27 - 31 Aug 2007 - URL: http://www.non-hodgkins-lymphoma-cancer.org/non-hodgkins-lymphoma-news.htm
... . Just as he finished that course a trial drug came on to the scene from the U.S., Mabthera, and the oncologist suggested Mr Dobson take this for a further four weeks. At the end of ...
Score: 6 - 15 Oct 2006 - URL: http://www.non-hodgkins-lymphoma-cancer.org/news/nhl-news0001.htm